IDStewardship
AUGUST 1, 2023
In this article, a pharmacist from Turkey with advanced training in the area of infectious diseases provides insights on antimicrobial stewardship in Turkey. Interview with: Emre Kara, MSc., Ph.D. Interviewer: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 1 August 2023 A man colonized with extensively drug resistant Acinetobacter baumannii gets on a plane.
Drug Topics
AUGUST 1, 2023
How many different ways can analytics assist your pharmacy? More than you may think. Mehrdad Hariri, RPh, CPh, MBA presented a session at July's Total Pharmacy Solution Summit on all the ways you can leverage those data for success.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
AUGUST 1, 2023
A new study revealed multiple locations across the southeast, including Georgia, Kentucky, and Florida, with areas that had high HIV risk but little-to-no preexposure prophylaxis services in the area.
Drug Topics
AUGUST 1, 2023
Hear the pharmacists from Eden Drug, Hazel Green, and Professional Pharmacy on their reactions to being a finalist for this award and more.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
AUGUST 1, 2023
Dostarlimab-gxly (Jemperli) approved in combination with carboplatin and paclitaxel for the treatment of adults with primary advanced or recurrent endometrial cancer that is mismatch repair deficient.
Drug Topics
AUGUST 1, 2023
Afoxolaner, moxidectin, and pyrantel chewable tablets protect dogs from fleas, ticks, heartworm disease, roundworms, and hookworms.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
AUGUST 1, 2023
A Q&A with Marc Ost, co-owner of Eric’s RX Shoppe, which was one of the first community pharmacies to receive the new vaccine.
Pharmacy Times
AUGUST 1, 2023
Despite the improvements in the patients' symptoms, minor adverse effects including urinary urgency and liver-related issues were reported.
Drug Topics
AUGUST 1, 2023
Is your pharmacy leaving revenue on the table by not having a year round vaccine program? Pacience Edwards, PharmD, answers that question and more during the July 2023 Total Pharmacy Solution Summit.
Pharmacy Times
AUGUST 1, 2023
Investigators found that age and the presence of RNAemia in blood were predictors of mortality in patients with severe COVID-19.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
AUGUST 1, 2023
Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, and Joseph Mann, MSN, FNP-C, discussed how streamlining the process of testing and prescribing could save time and energy for both pharmacies and patients.
Pharmacy Times
AUGUST 1, 2023
The health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Drug Topics
AUGUST 1, 2023
Hear Mike Vesely, Pharmacy Business Coach at DiversifyRx, and Mike Johnston, CPhT-Adv, BCSCPT, BCNCPT, founder and CEO of National Pharmacy Technician Association talk about how to streamline inventory, and why doing so is vital for pharmacies' success.
Pharmacy Times
AUGUST 1, 2023
The common diabetes drug could mediate hyperglycemia, which is caused when SARS-CoV-2 infects hepatocytes.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
AUGUST 1, 2023
Listen to the July 2023 Total Pharmacy Solutions Summit keynote session from Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association.
Fierce Healthcare
AUGUST 1, 2023
The U.S. Department of Labor is alleging UnitedHealth Group Inc. denied thousands of patients' payments for emergency room services and urinary drug screenings. | A third-party administrator of UnitedHealth Group denied thousands of emergency department and urinary drug screening claims without proper review, the U.S. Labor Department alleges in a lawsuit.
STAT
AUGUST 1, 2023
The U.S. Department of Labor claims in a new lawsuit that a UnitedHealth Group unit illegally rejected emergency room care and urine drug screen claims for thousands of people. UMR, Inc., a Wisconsin-based third-party administrator owned by UnitedHealth, manages benefits for more than 2,100 employee health plans. The federal government says the company denied ER visits and urine drug screens for years using a process that didn’t meet federal standards for health plans that employers fund
Fierce Pharma
AUGUST 1, 2023
As COVID-19 revenues ebb and flow—but mostly ebb—Pfizer is eyeing the cost-cutting shears. | Paxlovid generated just $143 million in worldwide sales for the second quarter, while mRNA vaccine Comirnaty brought home $1.4 billion. Against that backdrop, Pfizer reported total second quarter revenues of $12.7 billion, down a whopping 53% operationally from the same period last year.
STAT
AUGUST 1, 2023
For what would have been Henrietta Lacks’s 103th birthday, her family got her some justice: A settlement with Thermo Fisher Scientific over the Massachusetts-based company’s use of cells obtained without her consent seven decades ago. The story of Lacks, a Black woman whose cells have contributed to scientific breakthroughs ranging from the development of polio and cancer treatments to the mapping of the human genome, is one of the best-known tales of the exploitation of marginaliz
Fierce Healthcare
AUGUST 1, 2023
Amazon Clinic is expanding to all 50 states, including nationwide telehealth services to offer access to clinicians through its website and mobile app. | Amazon Clinic is expanding to all 50 states, including nationwide telehealth services to offer access to clinicians through its website and mobile app.
STAT
AUGUST 1, 2023
Harrison has an informal test that he runs on primary care physicians when he meets them for the first time: the eye contact test. When he arrives at the appointment and tells them that he’s transgender, he watches their eyes for a reaction. He’s looking for signs of shock — have they ever met a trans person before? Do they get nervous, or start talking at him, rather than with him?
Fierce Pharma
AUGUST 1, 2023
Bristol Myers Squibb and AstraZeneca have quickly resolved patent infringement lawsuits around their blockbuster cancer immunotherapies. | Bristol Myers Squibb and AstraZeneca have quickly resolved patent infringement lawsuits around their blockbuster PD-1/L1 and CTLA-4 cancer immunotherapies.
STAT
AUGUST 1, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Fierce Healthcare
AUGUST 1, 2023
Black parents and their children are at greater risk of experiencing unfair treatment in healthcare settings than those of other races and ethnicities, according to survey results collected in
STAT
AUGUST 1, 2023
Three large and growing physician groups backed by the private equity giant Welsh, Carson, Anderson & Stowe have hired a prominent lobbying firm to influence federal policy covering mergers and acquisitions. Over the past two weeks, United Musculoskeletal Partners, U.S. Anesthesia Partners, and U.S. Radiology Specialists each registered with Forbes Tate Partners, a lobbying shop founded by political insiders who used to work in President Bill Clinton’s administration.
Fierce Healthcare
AUGUST 1, 2023
Healthmap Solutions, a kidney population health management company, has raised $100 million to expand its business. | Healthmap, founded in 2016, serves payers and at-risk providers seeking value-based solutions for the high-risk, high-cost chronic kidney disease population.
STAT
AUGUST 1, 2023
I was in seat 20C on a flight home this March, when I felt my throat closing. Minutes earlier, hives had appeared on my face and chest. As a physician, I knew exactly what these symptoms meant: anaphylaxis, a severe allergic reaction so precipitously fatal that putting a breathing tube down someone’s throat is sometimes necessary. What I needed was an epinephrine autoinjector, also known as an EpiPen, but neither the airplane emergency medical kit nor any other passenger had one.
The Checkup by Singlecare
AUGUST 1, 2023
Most parents and caregivers expect kids to get sick from time to time. Usual signs of illness include body aches, fatigue, and loss of appetite. A fever is one of the most significant indicators that a child is sick. According to the National Institutes of Health (NIH), pediatric fever is often caused by a viral infection. Suppose your child is sick and has a fever.
STAT
AUGUST 1, 2023
For almost 44 years, Willie Bell never missed his appointment to check for prostate cancer. But then the pandemic hit. The doctor’s office was closed. Three months passed before he was able to be screened in January 2021. “So the doctor kept putting it off and I call him and say, ‘listen I get my PSA level checked every year. I would hate for you to tell me that you backed me off for a year, then you find cancer, because I’ll be pissed off,’” said Bell,
Fierce Pharma
AUGUST 1, 2023
Merck’s $10.8 billion acquisition of Prometheus Biosciences | Merck’s $10.8 billion acquisition of Prometheus Biosciences earlier this year gave the New Jersey company increased diversity in its portfolio, much needed considering its overwhelming dependence on cancer juggernaut Keytruda. But buying out the San Diego immunology specialist has not satisfied Merck’s appetite for M&A, executives said.
STAT
AUGUST 1, 2023
Last November, an employee at Intas Pharmaceuticals, which makes several widely used chemotherapies that are in short supply, was seen pouring acetic acid in a trash bin containing documents at a manufacturing facility. Another employee failed to report all test results on product samples and, at times, printouts were tossed in the trash. Plastic bags filled with torn and discarded important production records were stashed under a stairwell and on a truck parked outside.
Fierce Healthcare
AUGUST 1, 2023
Experts believe recent price transparency initiatives from the Centers for Medicare & Medicaid Services (CMS) are a step in the right direction but ultimately fall short of making the impact al | Price transparency initiatives could help consumers make better decisions with their wallets, but experts have tempered expectations of the real-world benefits for a recent CMS OPPS proposal.
STAT
AUGUST 1, 2023
WASHINGTON – The cannabis industry is dramatically scaling back its presence in Washington. Curaleaf, one the largest cannabis companies in the world, spent nearly 40% less on lobbying in the first half of 2023 than it did at its peak in 2019. Others like Columbia Care and Pax Labs got rid of their entire lobbying teams. Of the four major cannabis industry coalitions that have been pushing for federal legalization of marijuana the longest, one has seen its revenue cut in half; two others
Drug Store News
AUGUST 1, 2023
Items that fall under the Restored Premium category are like new, showing no signs of cosmetic damage, and they come with a one-year warranty and 30-day (or more) free returns.
Expert insights. Personalized for you.
212 
Let's personalize your content